Provide huge funds for advanced research on TB: Cong to Govt

Published On 2017-03-31 16:47 GMT   |   Update On 2017-03-31 16:47 GMT

New Delhi: Huge funds should be allocated for research organisations to discover advanced vaccines to tackle the dreaded tuberculosis (TB), a Congress member sought in the Rajya Sabha.Raising the issue during Zero Hour in the Upper House, Anand Bhaskar Rapolu said currently there is only BCG (bacille Calmette-Guerin) vaccine for new-born children and there was no advanced vaccination....

Login or Register to read the full article

New Delhi: Huge funds should be allocated for research organisations to discover advanced vaccines to tackle the dreaded tuberculosis (TB), a Congress member sought in the Rajya Sabha.


Raising the issue during Zero Hour in the Upper House, Anand Bhaskar Rapolu said currently there is only BCG (bacille Calmette-Guerin) vaccine for new-born children and there was no advanced vaccination. "With advanced stage of tuberculosis spreading infection to communities of lowest income groups, I urge upon the government to give prevention of tuberculosis and the necessity of advanced vaccines is highly required," he said.


An advanced vaccine will prevent the complication for which there is every necessity to support huge funds for research organisaions, he said.


Rapolu also sought that the government should administer three varieties of antibiotics and also provide nutritious food under 'Antyodaya Anna Yojana' under the Food Security law to TB affected patients.


Tuberculosis in India is a passive killer, killing above 5 lakh people every year, out of which 1 lakh people from multi-drug resistant tuberculosis, he added.

Tags:    

Disclaimer: This site is primarily intended for healthcare professionals. Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement/treatment or prescription. Use of this site is subject to our terms of use, privacy policy, advertisement policy. © 2024 Minerva Medical Treatment Pvt Ltd

Our comments section is governed by our Comments Policy . By posting comments at Medical Dialogues you automatically agree with our Comments Policy , Terms And Conditions and Privacy Policy .

Similar News